NCT04037826 - L. Reuteri DSM 17938 and L. Reuteri ATCC PTA 6475 in Moderate to Severe Irritable Bowel in Adults | Biotech Hunter

Enrollment

140

Participants

Timeline

Start Date

July 12, 2018

Primary Completion Date

September 30, 2019

Study Completion Date

December 30, 2022

Conditions

Irritable Bowel Syndrome

Interventions

DIETARY_SUPPLEMENT

L. reuteri DSM 17938 and L. reuteri ATCC PTA 6475

L. reuteri Gastrus (L. reuteri DSM 17938 and L. reuteri ATCC PTA 6475) at dose of 2x108 Colony Forming Units (CFU) per tablet. One chewable tablet is to be taken twice per day (one in the morning and one in the afternoon) giving a total daily dose of at least 4x108 CFU/day.

DIETARY_SUPPLEMENT

Placebo

Trial Locations (2)

14080

Hospital General Dr. Manuel Gea Gonzalez, Mexico City

Unknown

Instituto de Nutricion y Tecnologia de los Alimentos, Santiago